Prevalence of risk factors for chronic kidney disease among adults in a university community in southern Nigeria

Prevalence of risk factors for chronic kidney disease among adults in a university community in southern Nigeria

 

Chinyere Mmanwanyi Wachukwu^1,2,&, Pedro Chimezie Emem-Chioma^1,2, Friday Samuel Wokoma^1,2, Richard Ishmeal Oko-Jaja^1,2

 

¹Department of Medicine, Faculty of Clinical Sciences, College of Health Sciences, University of Port Harcourt, Nigeria, ²Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria

 

 

^&Corresponding author
Chinyere Mmanwanyi Wachukwu, Department of Medicine, Faculty of Clinical Sciences, College of Health Sciences, University of Port Harcourt, Nigeria, Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria

 

 

 

 

Chronic kidney disease (CKD) has become a major health concern globally, especially in developing countries with a marked burden in Sub-Saharan Africa [1]. This concern is largely due to the rising prevalence of risk factors such as type 2 diabetes, hypertension, and the HIV pandemic, the enormous cost implication of its treatment, its role in cardiovascular morbidity and mortality and the fact that the disease largely afflicts the economically productive younger age groups [1,2]. Several hospital based studies in Nigeria have put the prevalence of CKD between 1.6 - 12.4% [3] with a high prevalence of risk factors observed in various studies among different groups [4,5]. The early stages of CKD (stages 1-3a) are generally asymptomatic; therefore, the burden of the disease at these early stages goes largely undetected and difficult to assess. The symptoms only begin to manifest when greater than fifty percent of renal functional mass has been lost [6]. Most patients therefore present late to hospital, usually in the advanced diseased states and in need of salvage dialysis. As a result therefore, regular screening to aid early detection of risk factors is paramount in the prevention of CKD and ESRD. This need cannot be over-emphasized. The aim of this study was to determine the prevalence of risk factors for CKD among adults in a University community in the South-South Region of Nigeria, for early intervention in identified cases for prevention and delay of CKD progression.

 

 

This was a cross-sectional cohort study of adult volunteers in a University in the South-South region of Nigeria during the 2014 World kidney day exercise. Subjects for the study were mobilized through the University authorities. Verbal informed consent was obtained from each of the participants after a session of health education on kidney health. The study participants included consultant nephrologists, residents in internal medicine, house officers, medical students, and nephrology nurses, all of whom participated in data collection.

 

Clinical evaluation

 

Demographic data were obtained through interviewer-administered questionnaires and included age, sex, family and personal history of hypertension, diabetes and kidney disease. Pregnant women and individual with acute febrile illness were excluded from the study. Weight was measured with a standard measuring scale calibrated in kilograms with subjects standing erect, bare-foot, and without heavy clothing. Height was measured with a standiometer with subjects standing feet together without shoes or head gear. Body mass index (BMI) was calculated as body weight in kilograms divided by the square of the height in meters. Obesity was defined as BMI≥ 30kg/m^² according to the WHO guidelines [7]. Blood pressure was measured with a standard (Accosson) mercury sphygmomanometer on the patients' right arm in the seated position with feet on the floor after at least a five-minute rest. Systolic and diastolic blood pressures were taken at Korotkoff phases 1 and 5 respectively to the nearest 2 mmHg. The average of two blood pressure measurements taken five minutes apart was used. Hypertension was defined as SBP≥140mmHg and /or DBP≥90mmHg [8]. Elevated SBP was defined as SBP≥140mmHg and elevated DBP as DBP≥90mmHg.

 

Biochemical analysis

 

A sample of five millimetres (5mls) of venous blood was taken from each subject for assessment of serum creatinine. The samples were placed in lithium heparin bottles (gently mixed) and transported immediately to the chemical pathology laboratory. Proteinuria and glycosuria were assessed in subjects' urine using combi-2 dipstick. Proteinuria and glycosuria were defined as the presence of at least 1+ of protein and 1+ of glucose on dipstick respectively. Random blood sugar was measured using the Accucheck Glucometer, and results were expressed in mmol/l. Hyperglycaemia was defined as random blood sugar > 11.1mmol/l (>200mg/dl). The Glomerular filtration rate was estimated using the Cockcroft-Gault equation [9] with correction for body surface area (BSA). Body surface area was calculated using the DuBois and DuBois formula [10].

 

Statistical analysis

 

Collated data were analysed using statistical package for social sciences (SPSS) version 17.0 analytic software. Continuous variables were compared with the independent samples T-test and the Chi-square test was used to compare categorical variables. Pearson correlation was used to analyse the relationship between variables.

 

 

Demographic and clinical characteristics of subjects:

 

A total of 259 subjects were screened for CKD in this study. The mean age of subjects in the study was 28.3±9.7 years with a range of 16 to 66years. Majority of the study population 235(90.7%) were less than 45 years, 23(8.9%) were between 45 years and 65 years. Only one subject (0.4%) was over 65 years. There were more males than females, 135 (52.1%) and 124 (47.9%) respectively. Personal history of hypertension, diabetes and CKD was obtained in 10(3.9%), 5(1.9%) and 4(1.5%) subjects respectively. Family history of hypertension and diabetes was obtained in 87(33.6%) and 66(25.5%) of subjects respectively and only 4(1.5%) subjects had a family history of CKD.

 

Clinical characteristics of study group

 

The weight in kilograms was significantly higher among the male subjects, though no statistical significant difference was observed in the BMI among the male and female subjects. The systolic and diastolic blood pressures were higher the male population, with a lower eGFR observed among the female population. These results were statistically significant. The clinical characteristics of the study group are shown in Table 1.

 

Frequency of risk factors for CKD

 

Hypertension was observed in 20.8% of subjects, 12.2% of subjects were obese and 4.3% had hyperglycaemia. The eGFR was less than 60mls/min/1.73m² in 1.9% of subjects. The frequency of risk factors for CKD are shown in Figure 1. There was a significant negative correlation between age of subjects and eGFR but no significant association was observed between eGFR and either systolic or diastolic blood pressures. This is as shown in Table 2.

 

 

The mission of the world kidney day is to raise global awareness of the importance of the kidneys to overall health, [11] thereby reducing the frequency of CKD and its attendant burden. Population-based education and screening programmes, as were carried out in this study, are intended to increase the rates at which subjects with kidney disease will be detected, enabling further evaluation of those identified and permitting disease modifying interventions to be instituted [12]. The risk factors of CKD screened for in this population included hypertension, obesity, hyperglycaemia, proteinuria, glycosuria as well as eGFR. The prevalence of hypertension observed in this study was 20.8%; this falls within the range of the overall prevalence of hypertension in Nigeria reported to be between 8.0- 46.4% [13]. Ordinioha [14] reported a similar prevalence of 21.3% among lecturers in Port Harcourt. Similarly a report among civil servants in Kano [15] showed a prevalence of 29.8%. Hypertension remains among the top three causes of CKD in Nigeria [16,17] and is also a common cause of CKD in other parts of Sub-Saharan Africa [1] and when uncontrolled, it is known to hasten the progress of CKD as well as increase cardiovascular complications. This relatively high prevalence of hypertension may be associated with increasing urbanization, and adoption of western lifestyle in this environment. According to the World Health Organisation (WHO), in 2014, more than 1.9billion persons worldwide were overweight and of these greater than 600 million were obese.[18] Sub-Saharan Africa is not exempt from the obesity epidemic and Abubakari et al [19]in a review reported an obesity prevalence of 10% among West African adults. In this study, the prevalence of overweight and obesity was comparable to that earlier reported in a systematic review among adult Nigerians [20]. This relatively high prevalence of overweight and obesity observed in this study can be attributed to increased popularity in this environment of western diets rich in sugar, saturated fats and refined carbohydrates.

 

There is also an apparent upsurge in the consumption of fast foods; this with sedentary lifestyles may encourage the development of obesity. The commonest risk factors for CKD remain diabetes and hypertension [16,17] and these conditions are known to be strongly associated with obesity. Obesity has been shown to have effects independently impacting on renal haemodynamics and its tendency to cause and/or increase proteinuria may account for its strong association with worsening progression of CKD [21,22]. Hyperglycaemia in this study was observed in 4.3% of the participants, comparable to that observed in other studies.[4,5] In Port Harcourt, Nigeria, the prevalence of diabetes was reported to be 6.8% among adults [23] and Nigeria is also said to have the largest number of people with type 2 diabetes mellitus in Africa [24]. Diabetes is also known to be the leading cause of CKD worldwide [25] and is gaining an increasing important role as a cause of CKD and ESRD in Sub-Saharan Africa [1] and in Nigeria [26], therefore this prevalence observed here poses a cause for concern. The prevalence of proteinuria in this study was 12.4%. A higher prevalence of 19.4% was reported among civil servants in Kano [15], while a lower prevalence of 5.6% was observed among civil servants in Bayelsa.[4] This high prevalence observed in this study is perturbing in this unselected apparently healthy population of young people. Proteinuria is an independent risk factor and an early indicator of kidney disease and its persistence is known to be associated with progression of kidney disease [27]. The prevalence of CKD (eGFR< 60mls/min/1.73m²) 1.9% in this cohort was low compared to recent reports in Nigeria [4,28]. This is due to the relative young study population. Secondly the study is among a cohort of University population who are predominantly healthy. It is also well known that the eGFR declines with increasing age. This study also showed a significant negative correlation between age and eGFR. Action taken on subjects in whom risk factors of CKD were detected: these subjects were counselled and referred to the University Health Centre for further follow up. This study may have been limited by its cross-sectional nature (as the participants were not screened again to determine if there will be persistence of these risk factors), the probable narrow social strata of the study population and the method employed for assessing proteinuria.

 

 

Though the prevalence of e-GFR<60mls/min/1.73m in this population was relatively low, the prevalence of CKD risk factors was substantial. This underscores the need for reinforced population-wide health education and screening programmes for early detection of these modifiable risk factors to prevent and reduce the prevalence and burden of CKD and its sequelae in Nigeria.

 

 

The authors declare no competing interests.

 

 

Chinyere Wachukwu conceived the idea for the study. All authors participated during data collection during the 2014 World kidney day. The Manuscript was drafted by Chinyere Wachukwu including the statistical analysis. All authors have read and agreed to the final version of this manuscript and have equally contributed to its content and to the management of the case.

 

 

We acknowledge the Internal medicine resident doctors, House officers, Renal nurses and medical students who participated in the field during the exercise.

 

 

Table 1: clinical and biochemical characteristics of study population

Table 2: correlation of eGFR with clinical parameters

Figure 1: frequency of risk factors for CKD among the study population

 

 

1. Naicker S. End-stage renal disease in Sub-Saharan Africa. Ethn Dis Spring. 2009; 19(1 Suppl 1): S1-13. PubMed | Google Scholar


2. Rashad S, Basroum MD. Chronic kidney disease in the developing world. N Engl J Med. 2006 March; 354(10): 997-999. PubMed | Google Scholar


3. Odubanjo MO, Oluwasola AO, Kadiri S. The epidemiology of end-stage renal disease in Nigeria: The way forward. Int Urol Nephrol. 2011 Sep; 43(3):785-792. PubMed | Google Scholar


4. Egbi OG, Okafor UH, Miebodei KE, Kaia BE, Kunle-Olowu OE, Unuigbe EI. Prevalence and correlates of chronic kidney disease among civil servants in Bayelsa State, Nigeria. Niger J Clin Pract. 2014 Sep; 17(5):602- 607. PubMed | Google Scholar


5. Okaka EI, Adejumo OA, Ojeh-Oziegbe OE, Olokor AB, Iyawo IO. Spot assessment of chronic kidney disease risk factors in a market population in Benin city. Afr J Med Health Sci. 2013 Jan-Jun; 12(1):10-14. PubMed | Google Scholar


6. Obrador GT. Chronic renal failure and the uremic syndrome In: Lerma EV, Berns JS, Nissensen AR, editors. Current Diagnosis and treatment: Nephrology and Hypertension. 1st ed McGraw Hills 2009: 149. Google Scholar


7. Waist circumference and waist-hip ratio: report of a WHO expert consultation. Geneva, 8-11 December 2008. Assessed on 19/2/2015. Available from www.whqlibdoc.who.int/publications/2011/9789241501491_eng.pdf. Google Scholar


8. Chobain AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. The seventh report of the Joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. JAMA. 2003 May; 289(19):2560-2572. PubMed | Google Scholar


9. Cockcroft DW, Gault MH. Prediction of creatinine clearance using serum creatinine. Nephron. 1976; 16(1):31-41. PubMed | Google Scholar


10. DuBois D, DuBois EF. A formular to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916 Jun; 17(6):863-871. PubMed | Google Scholar


11. World kidney day: our mission. Assessed on 23/3/2015. Available from www.worldkidneyday.org. Google Scholar


12. McClellan WM, Ramirez SPB, Jurkovitz C. Screening for chronic kidney disease: Unresolved Issues. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):81-87. PubMed | Google Scholar


13. Ogah OS, Okpechi I, Chukwuonye II, Akinyemi JO, Onwubere BJC, Falase AO et al. Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. World J Cardiol. 2012 Dec; 4(12): 327-340. PubMed | Google Scholar


14. Ordinioha B. The prevalence of hypertension and its modifiable risk factors among lecturers of a medical school in Port Harcourt, south-south Nigeria: Implications for control effort. Niger J Clin Pract. 2013 Feb; 16(1):1-4. PubMed | Google Scholar


15. Nalado AM, Abdu A, Muhammad H, Abdu A, Sakajiki AM, Adamu B. Prevalence of risk factors for chronic kidney disease among civil servants in Kano. Niger J Basic Clin Sci. 2012 Jul-Dec; 9(2): 70-74. PubMed | Google Scholar


16. Akinsola W, Odesanmi WO, Ogunniyi JO, Ladipo GO. Diseases causing chronic renal failure in Nigerians- a prospective study of 100 cases. Afr J Med Med Sci. 1989 Jun; 18(2): 131-137. PubMed | Google Scholar


17. Alebiosu CO, Ayodele OO, Abbas A, Olutoyin AI. Chronic renal failure at the Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria. Afr Health Sci. 2006 Sep; 6(3): 132-138. PubMed | Google Scholar


18. Obesity and overweight. World Health Organization. Updated Janurary 2015. Assessed 3rd April 2015. Available from www.who.int/mediacentre/factsheets/fs311/en/. Google Scholar


19. Abubakari AR, Lander W, Agyemang C, Jones M, Kirk A, Bhopal RS. Prevalence and time trends in obesity among West African populations: a meta-analysis. Obesity Reviews. 2008 July; 9(4): 297-311. PubMed | Google Scholar


20. Chukwuonye II, Chuku A, John C, Ohagwu KA, Imoh ME, Isa SE et al. Prevalence of overweight and obesity in adult Nigerians: a systematic review. Diabetes Metab Syndr Obes. 2013 Jan; 6: 43-47. PubMed | Google Scholar


21. Eknoyan G. Obesity and chronic kidney disease. Nefrologia. 2011 May; 31(4): 397-403. PubMed | Google Scholar


22. Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Neprol. 2013 Jan; 33(1): 14-22. PubMed | Google Scholar


23. Nyenwe EA, Odia OJ, Ihekwaba AE, Ojule A, Babatunde S. Type 2 Diabetes in adult Nigerians: a study of its prevalence and risk factors in Port Harcourt, Nigeria. Diabetes Res Clin Pract. 2003 Dec; 62(3): 177-185. PubMed | Google Scholar


24. International working group on the diabetic foot. Assessed on 3rd April 2015. Available from http//www. Idf.org/webdata/docs/background_info_AFR.pdf.. Google Scholar


25. Atkins RC. The epidemiology of chronic kidney disease. Kidney Int. 2005 Apr; 67(Suppl 94): 14-18. PubMed | Google Scholar


26. Alebiosu CO, Ayodele OE. The increasing prevalence of diabetic nephropathy as a cause of end stage renal disease in Nigeria. Trop Doct. 2006 Oct; 36(4): 218 - 219. PubMed | Google Scholar


27. Abbak M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage?. JASN. 2006 Nov; 17(11): 2974-2984. PubMed | Google Scholar


28. Ulasi II, Ijoma CK, Onodugo OD, Arodiwe EB, Ifebunandu NA, Okoye JU. Towards prevention of chronic kidney disease in Nigeria: a community-based study in Southeast Nigeria. Kidney Int Suppl. 2013 May; 3(2): 195-201. PubMed | Google Scholar